Video: John Crowley of Amicus Therapeutics presents opening remarks at World Orphan Drug Congress USA 2012
As well as Amicus Therapeutics, Mr. Crowley has also held senior positions at Orexigen Therapeutics, Genzyme Therapeutics, and Novazyme Pharmaceuticals. Indeed, he founded Novazyme, a company that was developing a novel treatment for Pompe disease, in large part due to the diagnosis of this rare disease in two of his children.
As such, John Crowley is certainly more than qualified to speak on orphan drugs, from the perspective of the caregiver and the perspective of industry.
Check out the video below!
The World Orphan Drug Congress USA is North America’s largest commercially-focused orphan drug event. Download the prospectus for more information.